Compound Summary
药名: | cudraflavone b;Mulberrochromene |
别名: | CHEMBL221907; 2-(2,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methylbut-2-enyl)pyrano[5,6-g]chromen-4-one; 8-(2,4-dihydroxyphenyl)-5-hydroxy-2,2-dimethyl-7-(3-methylbut-2-en-1-yl)-2H,6H-pyrano[3,2-g]chromen-6-one; cid_5319925; 2-(2,4-dihydroxy-phenyl)-5-hydroxy-8,8-dimethyl-3-(3-methyl-but-2-enyl)-8H-pyrano[3,2-g]chromen-4-one; 2-(2,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methylbut-2-enyl)-4-pyrano[5,6-g]chromenone; BDBM50193718; MLS000697596; mulberrochromene; AC1NSYTH; cudraflavone B; 8-(2,4-dihydroxyphenyl)-5-hydroxy-2,2-dimethyl-7-(3-methylbut-2-enyl)pyrano[3,2-g]chromen-6-one; HMS2268D05; SMR000470934; CHEBI:67850; 19275-49-1; 2-(2,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methylbut-2-enyl)pyrano[3,2-g]chromen-4(8H)-one |
分子式: | C25H24O6 |
Smiles: | CC(=CCC1=C(OC2=CC3=C(C=CC(O3)(C)C)C(=C2C1=O)O)C4=C(C=C(C=C4)O)O)C |
成分: | HBIN021878;HBIN035897 |
OB_score: | 10.075347 |
CAS_id: | 62596-29-6 |
SymMap_id: | SMIT03265;SMIT18867 |
TCMID_id: | 25464 |
TCMSP_id: | MOL000727 |
PubChem_id: | 5319925 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE006099 | 桑白皮 | Lung heat cough asthma, water-rheum collecting lung, distention fullness and rapid asthma, edema, beriberi, inhibited urination. | ||||
TCMBANKHE008697 | Caulis Aristolochiae seu Clematis | 木通 | 1. To promote water metabolism and relieve abnormal urination; 2. To clear heat and promote lactation/Acute urethritis, short voidings of reddish urine, strangury-turbidity, edema, nephritis with edema, galactostasis, heat vexation in chest, throat pain, mouth sore, tongue sores, wind-damp impediment pain, galactostasis, amenorrhea, dysmenorrhea. | |||
TCMBANKHE007773/YEM-590/XU-716 | Ramulus Mori|Morus alba L.|Morus alba | 桑枝|桑 | 桑叶 | 云南民族药物志:第三卷|云南省昭通市盐津县 | To relieve rheumatic arthralgia./Hypertension, aching pain in joints, numbness in joints. | 阿昌族/布依族/傣族/德昂族/哈尼族/景颇族/傈僳族/苗族/水族/佤族/彝族/藏族 |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000294 | CDKN1A | CAP20; CDKN1; CIP1; MDA-6; P21; SDI1; WAF1; p21CIP1 | cyclin dependent kinase inhibitor 1A |
TCMBANKGE000825 | CDKN1B | CDKN4; KIP1; MEN1B; MEN4; P27KIP1 | cyclin dependent kinase inhibitor 1B |
TCMBANKGE001132 | BAX | BCL2L4 | BCL2 associated X, apoptosis regulator |
TCMBANKGE001156 | CASP3 | CPP32; CPP32B; SCA-1 | caspase 3 |
TCMBANKGE001166 | BCL2 | Bcl-2; PPP1R50 | BCL2 apoptosis regulator |
TCMBANKGE001177 | TP53 | BCC7; BMFS5; LFS1; P53; TRP53 | tumor protein p53 |
TCMBANKGE001182 | SIRT1 | SIR2; SIR2L1; SIR2alpha | sirtuin 1 |
TCMBANKGE001201 | MAPK3 | ERK-1; ERK1; ERT2; HS44KDAP; HUMKER1A; P44ERK1; P44MAPK; PRKM3; p44-ERK1; p44-MAPK | mitogen-activated protein kinase 3 |
TCMBANKGE001203 | MAPK1 | ERK; ERK-2; ERK2; ERT1; MAPK2; P42MAPK; PRKM1; PRKM2; p38; p40; p41; p41mapk; p42-MAPK | mitogen-activated protein kinase 1 |